Halo Sign and Reverse Halo Sign in a Patient with Primary Lung Adenocarcinoma: A Case Report.

Pouyan Ebrahimi, Hamidreza Jamaati, Amir Morteza Soleimani

Abstract readCase Reports

In one paragraph

Article in Tanaffos, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Pouyan EbrahimiStudent Research Committee, Babol University of Medical Science, Babol, Iran.

Hamidreza JamaatiChronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Amir Morteza SoleimaniChronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The halo sign and reverse halo sign are two computerized tomography scan views based on the placement of ground glass opacity. These two views have various differential diagnoses, but infections are known to be the most important differential diagnosis in both views. Lung adenocarcinoma, one of the deadliest tumors of both genders, can be included in the differential diagnosis. Nevertheless, we decided to report this case since both of these features were present in the same patient. Case Presentation: A 51-year-old man presented with gradual symptoms such as shortness of breath and myalgia, with a history of smoking and coronavirus disease 2019. In his computerized tomography scan, two views of the halo sign and the reverse halo sign were seen along with other lesions. In further investigations, due to his lack of recovery, a biopsy was prepared. Finally, with a definitive diagnosis of lung adenocarcinoma, we treated the patient appropriately. Conclusion: When a patient presents with a halo sign and reverse halo sign on a computerized tomography scan and has a smoking history, it is necessary to take a biopsy of the observed lesions to rule out primary lung carcinoma.

Indexed as

Adenocarcinoma of the lungLung neoplasmsReversed halo signTomography X-ray computed

Identifiers

PMID39959800

PMCPMC11825078

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.